Altris
3 known investors
Altris AI provides an AI platform for analyzing OCT (optical coherence tomography) retina scans, detecting and quantifying 30+ retina pathologies and 40+ biomarkers to support diagnostic decisions, patient triage, and treatment monitoring. It serves ophthalmologists, optometrists, and pharma/clinical research teams, offering vendor-neutral OCT analysis, early glaucoma risk detection, and tools to accelerate clinical trial patient enrollment.
Investors · 3
Frequently asked questions
- What does Altris do?
- Altris AI provides an AI platform for analyzing OCT (optical coherence tomography) retina scans, detecting and quantifying 30+ retina pathologies and 40+ biomarkers to support diagnostic decisions, patient triage, and treatment monitoring. It serves ophthalmologists, optometrists, and pharma/clinical research teams, offering vendor-neutral OCT analysis, early glaucoma risk detection, and tools to accelerate clinical trial patient enrollment.
- Who are Altris's investors?
- Altris's investors include Brinc, Runa Capital, SID Venture Partners.